MentionFox
Home › funding signals › Gossamer Bio, Inc.
Company · SEC filings

Gossamer Bio, Inc. funding history

Before you sign with, sell to or invest in Gossamer Bio, Inc.

MentionFox check on Gossamer Bio, Inc.: no red flags found in 5 sources; 3 items to note (checked 10 November 2026). mentionfox.com/c/company/gossamer-bio-inc

  • Note: Shareholder or securities suit filed Jun 2026 (court record)
  • Note: Shareholder or securities suit filed Mar 2026 (court record)
  • Note: Shareholder or securities suit filed Apr 2020 (court record)

Check Gossamer Bio, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Gossamer Bio, Inc.?

Gossamer Bio, Inc. has 2 Form D filings on record, from 2023-08-07 to 2026-09-04. Together its new offerings report $237.10M sold.

In its own words: “Science Seralutinib Seralutinib is an inhaled PDGFRα/β, CSF1R, and c‑KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).” (gossamerbio.com, checked November 1, 2026)

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Gossamer Bio, Inc.: Raised $25M, Form D filed 2026-09-04
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

Companies that share a holder

What do you want to do with Gossamer Bio, Inc.?

Is Gossamer Bio, Inc. a real, registered company?

Gossamer Bio, Inc. is a registered filer with the SEC (CIK 1728117) and has filed since 2023-08-07. 2 filings are on record, the latest on 2026-09-04.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Gossamer Bio, Inc.?

Gossamer Bio, Inc.'s filings name Bryan Giraudo, Caryn Peterson, Christian Waage and 13 more as its officers, directors or promoters.

How much has Gossamer Bio, Inc. raised?

Its new offerings report $237.10M sold across 2 offerings, as its own filings state.

Run the free check on Gossamer Bio, Inc. →

Based
San Diego, CALIFORNIA
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$237.10M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-09-04New offering
first sale 2026-08-20
$25M$150Mdetails · SEC filing
2023-08-07New offering
first sale 2023-07-24
$212.10M$212.10MSEC filing

Want the whole picture on Gossamer Bio, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Gossamer Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Gossamer Bio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    6 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Gossamer Bio, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Who owns it

Fundraising filings

Leadership changes

5%+ stakes

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Gossamer Bio, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Cite this page

Permanent URL: https://mentionfox.com/company/gossamer-bio-inc
Last updated 2026-11-10
Primary record: SEC filing 1 · SEC filing 2
How much has Gossamer Bio, Inc. raised? $237.10M in 2 SEC filings. MentionFox, 2026-11-10. https://mentionfox.com/company/gossamer-bio-inc